Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1996;87:74-78
© 1996 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, J.
Right arrow Articles by Devonald, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, J.
Right arrow Articles by Devonald, K.

Articles

A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow

JM Morris, RA Fay, DA Ellwood, CM Cook, and KJ Devonald

OBJECTIVE: To evaluate color Doppler imaging of the uterine arteries as a screening test in nulliparous women, and to examine the role of low-dose aspirin therapy in pregnancies with abnormal uteroplacental resistance. METHODS: At the routine 18-week fetal morphology ultrasound scan, 955 nulliparous women underwent color Doppler imaging of the uterine arteries. Abnormal uteroplacental vascular resistance was defined with respect to both the systolic-diastolic ratio of the flow velocity waveform and the presence of an ipsilateral early diastolic notch. Those with abnormal uterine artery waveforms were asked to participate in a randomized controlled trial of aspirin therapy. Pregnancy outcomes were compared in women with normal or abnormal flow velocity waveforms, as well as in the two arms of the intervention study. RESULTS: Of 186 women with abnormal uteroplacental resistance according to criteria defined previously, 102 agreed to randomization to either low-dose aspirin (100 mg/day) or placebo for the remainder of the pregnancy. Abnormal uterine artery flow velocity waveforms were associated with statistically significant increases in preeclampsia (11 versus 4%), birth weight below the tenth percentile (28 versus 11%), and adverse pregnancy outcome (45 versus 28%). Prophylactic aspirin therapy did not result in a significant reduction in pregnancy complications. CONCLUSION: Abnormal uteroplacental resistance at 18 weeks' gestation was associated with a significant increase in adverse pregnancy outcome. Low-dose aspirin did not reduce pregnancy complications in women with uteroplacental insufficiency.


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
V. Berghella
Prevention of Recurrent Fetal Growth Restriction
Obstet. Gynecol., October 1, 2007; 110(4): 904 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. Conde-Agudelo, J. Villar, and M. Lindheimer
World Health Organization Systematic Review of Screening Tests for Preeclampsia
Obstet. Gynecol., December 1, 2004; 104(6): 1367 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. Coomarasamy, S. Papaioannou, H. Gee, and K. S. Khan
Aspirin for the Prevention of Preeclampsia in Women With Abnormal Uterine Artery Doppler: A Meta-Analysis
Obstet. Gynecol., November 1, 2001; 98(5): 861 - 866.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Obstetricians and Gynecologists.